At our financial performance in the third quarter, firstly, our profit before tax was €45 million. This was down 46% compared to the third quarter of 2023. But our capital light business continued its strong performance with good volume growth and stable fee margins. And as Petra mentioned, our assets under management grew by 18% year on year to €13.3 billion. The cost income ratio of our client AUM continues to improve to 63%, and our organic capital generation was $0.11 for the quarter and $0.34 year to date. And as you all know, this is the key parameter to look at when assessing our dividend generation during the year.
Return on equity in the third quarter was 9.4%. And if we then look closer at the different result components, as Patrick mentioned, our fee result was up 42% year on year, with AUM up 18%. And if we adjust for some €2 million of holding company costs that are now reported under other, which were previously included in the fee result, the underlying growth was around 25%. We've clearly focused on the expense side, which also contributed positively to the fee result in the third quarter. Within the fee result, the fees from investment and asset management services were up around 60%. At the same time, the other part of the fee result or the insurance service result from the CSM release was largely unchanged, like in previous quarters. Our net finance result came in at €27 million, which is below the historical average. As you can see. As you all know, the market interest rates fell significantly during the quarter, and this overall had an €81 million accounting headwind in Q3. However, we were able to generate a good investment return. And this more than offset the negative discounting and unwinding impact. On the positive side, we had a €9 million positive impact from our holdings at the end of this quarter. Our result related to risk policies, which is also an important part of our capital light offering, continued to develop positively. Volumes continued to increase, and we continue to have a positive expense and claims experience. Variants. In addition, the result included a €3 million one-off CSM release related to the portfolio transfer to If P&C. The Group Net finance result decreased to €27 million, and in the With-profit segment, it was down to €18 million. The with profit investment return in the quarter was 2.4%, or 9.6% annualized, and it was clearly higher than last year. Our with-profit fixed income assets continue to generate good returns with a mark-to-market yield of 4.8%. When adjusting for the increase in cash from our September €300 million Tier 2 issue. Note that our old €250 million bond was repaid only at the beginning of October. However, the higher share of lower-return money market instruments had an impact on the total yield during the quarter, as we typically have a higher cash weight to prepare to upstream internal dividends to the holding company towards the end of the year. Equities contributed positively this quarter, but it's good to remember that our own equity portfolio is not an indexed portfolio. So the return was below international benchmarks. In the third quarter, we further decreased our equity weight. And as you all know, this is in line with our long-term allocation strategy. Private equity had a bit of a slower quarter, but private debt was at a more normal quarter with a 2.6% investment return. The lower discount rate had a 62 million negative P&L impact, as market interest rates fell by 50 to 80 basis points in the quarter. The unwinding cost remained stable throughout the year. I think it's important to also remember that declining market interest rates, especially at the long end of the yield curve, have a negative impact on the PNL of the quarter. Q3 shows that our hedging strategies worked well even in a quarter when rates fell dramatically. And even more importantly, it's worth remembering that our future profit generation is a function of the investment return we can achieve above the discount rate, not the actual level of the interest rates, and this spread has remained largely unchanged. Our organic capital generation, or OCG, was €54 million in Q3, and this translates to $0.34 per share during the first nine months of the year. In addition to reported profits, this measure also takes into account the own funds generation from the income booked in the CSM, as well as potential capital release from the SCR. As we've said before, we think the OCG is a more relevant measure than the reported IFRS result when assessing our financial performance and dividend generation in particular, and in a normal quarter, you should still continue to expect that the OCG is higher than the reported PNL result. Our dividend-adjusted solvency margin remained unchanged quarter on quarter at 224%. Own funds increased, but the SCR also increased during the quarter, primarily due to lower bond yields. And as you can see, our solvency margin is robust in different stress scenarios as well. And now I'll hand it over to Petri for some concluding remarks.